 |
About Us |
Berean Development, Inc.
Berean Development Inc. is dedicated to the research
and development of bioceutical compounds effective
in the support of a healthy immune system. Berean
targets its research to the development of compounds
whose mechanism of activity targets the blocking of
ion channels in certain lymphocytic T-Cells, thereby
prohibiting the cascade of events leading to
inflammatory responses.
We are
a biotechnology company focusing on the development
of naturally occurring
compounds for better health. Developing products by reverse engineering the symplexes,
ligands and constellation of modalities that cascade and eventuate
into the expression of the Proto-Oncogene.
The chemical make-up of Berean’s complexes contains several
bioactive molecules that are proprietary to the company as novel immunotherapeutics. Over the past
decade, Berean has been able to
research, synthesize and validate - in vitro and in vivo, in animals
and in man - the suppression of gene expression by blockade of
patented gene voltage-gated potassium channels. Berean’s key
bioactive ingredients effect the blockage of these channels, which
cause proliferation of the disease-signaling NK CD8 negative T-Cells. The
pathogeneses of these cells induce various autoimmune responses
which Berean seeks to reverse and abate
History
We have developed, through collaborative agreements, the
synthesis of our proprietary compounds. The synthesis allows us to
maintain constant efficacy and quality control, and to provide
patent “suites” to protect Berean’s position. Berean’s products are
protected under various US and foreign patents.
Customer Care
( 888-Mirac-11
(888-647-2211)
Email
Us:
|
